✦ LIBER ✦

New Insulin Glargine 300 U/mL: Efficacy and Safety of Adaptable vs. Fixed Dosing Intervals in People with T2DM

✍ Scribed by Rabasa-Lhoret, Remi; Riddle, Matthew C.; Bolli, Geremia B.; Home, Phillip D.; Bergenstal, Richard; Ziemen, Monika; Muehlen-Bartmer, Isabel; Wardecki, Marek; Vinet, Laetitia; Yki-Järvinen, Annele

Book ID: 126818486
Publisher: Canadian Diabetes Association
Year: 2014
Tongue: English
Weight: 53 KB
Volume: 38
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2014.07.147

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New Insulin Glargine 300 U/mL: Glycemic

New Insulin Glargine 300 U/mL: Glycemic Control and Hypoglycemia in Insulin-Naïve People with T2DM (EDITION 3)

✍ Bajaj, Harpreet S.; Bolli, Geremia B.; Riddle, Matthew C.; Bergenstal, Richard; 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 75 KB

Less Nocturnal Hypoglycemia and Weight G

Less Nocturnal Hypoglycemia and Weight Gain with New Insulin Glargine 300 U/mL Compared with 100 U/mL: 1-Year Results in People with T2DM Using Basal Insulin with OADs (EDITION 2)

✍ Goldenberg, Ronald; Yki-Järvinen, Hannele; Bergenstal, Richard M.; Bolli, Geremi 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 197 KB

Sustained Glycemic Control and Less Hypo

Sustained Glycemic Control and Less Hypoglycemia with New Insulin Glargine 300 U/mL Compared with 100 U/mL: 1-Year Results in People with T2DM Using Basal + Mealtime Insulin (EDITION 1)

✍ Leiter, Lawrence A.; Riddle, Matthew C.; Bolli, Geremia B.; Yki-Järvinen, Hannel 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 190 KB

New Insulin Glargine 300 U/mL: Glycemic

New Insulin Glargine 300 U/mL: Glycemic Control and Hypoglycemia in a Meta-Analysis of Phase 3a EDITION Clinical Trials in People with T2DM

✍ Hramiak, Irene; Ritzel, Robert; Roussel, Ronan; Bolli, Geremia B.; Vinet, Laetit 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 50 KB